Product Introduction:
Cyblex MV Tablet combines Teneligliptin, Metformin, and Pioglitazone to provide effective glycemic control in type 2 diabetes patients. This triple combination targets multiple pathways to lower blood sugar and improve insulin function.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Control of high blood glucose levels
-
Prevention of diabetes-related complications
Benefit:
-
Improves insulin sensitivity (Pioglitazone)
-
Decreases hepatic glucose production (Metformin)
-
Enhances insulin secretion (Teneligliptin)
-
Supports overall diabetes management for better glycemic control
Composition:
-
Teneligliptin 20 mg
-
Metformin Hydrochloride 500 mg
-
Pioglitazone 40 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Weight gain (especially due to Pioglitazone)
-
Edema or fluid retention
-
Gastrointestinal issues (nausea, diarrhea)
-
Headache and dizziness
-
Rare allergic reactions
Safety Advice:
-
Alcohol: Avoid or limit alcohol consumption
-
Pregnancy/Breastfeeding: Use only if prescribed by a healthcare provider
-
Heart Failure: Use cautiously as Pioglitazone may cause fluid retention
-
Kidney/Liver Function: Regular monitoring recommended
-
Lifestyle: Maintain diet and exercise as advised by your doctor
